KYORIN PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,657 JPY | +0.18% |
|
-3.38% | -6.91% |
| 2023 | ATyr Pharma to Obtain $10 Million in Milestone Payment After Partner Starts Dosing Patients in Lung Disease Study in Japan | MT |
| 2021 | KYORIN Holdings, Inc.(TSE:4569) dropped from S&P Japan 500 | CI |
Evolution of the average Target Price on KYORIN Pharmaceutical Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
a988fa0cbd77f33996596c13.V1wNwx26tdsBBjC_xKE-WYnk-qGgVx1ffOO_yyU7U_o.OGphsknY47pEPwHbp5lSbcOuotLoPSgxS6GIsxdyMc4SMGOoLeiGqzhUQw~18c35eb555ace187690aeb38189f3a49
Analysts' Consensus
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
1
Last Close Price
1,657
JPY
Average target price
1,300
JPY
Spread / Average Target
-21.54%
High Price Target
1,300
JPY
Spread / Highest target
-21.54%
Low Price Target
1,300
JPY
Spread / Lowest Target
-21.54%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 4569 Stock
- Consensus KYORIN Pharmaceutical Co., Ltd.
